Atezolizumab,vinorelbine
roche
['agent', 'platinum', 'atezo']
ipsos study evaluating single agent chemo and atezo in pts ineligible for platinum doublet (poor ps). 10.3 vs. 9.2 months in favour of atezo (hr 0.78) interesting early cross over in os curves. #esmo2022 
Thoracic Medical Oncologist @BartsHospital, PhD in genomic medicine @Imperialcollege, Representative @ACPUK & @BTOGorg, @FMLM_UK clinical Fellow ‘18 #SE15